The 2020 Annual Forum on Cutting-edge Technologies in Drug Formulation has successfully concluded.

From December 10 to 11, 2020, in Shanghai, Haibu Pharmaceutical was invited to participate in and host the 2020 Annual Frontier Technology Summit Forum on Drug Formulation, jointly organized by the Pharmaceutical Sciences Committee of the Shanghai Pharmaceutical Association and the School of Pharmacy at Fudan University. This forum provided a high-level technical exchange platform for the development of the pharmaceutical industry, sharing achievements and experiences, and jointly discussing the challenges faced in drug research and regulation.

This forum invited top experts from both domestic and international pharmaceutical fields to share and communicate with participants on cutting-edge technologies related to complex injectables, complex solid formulations and processes, inhalation formulations, biological preparations, etc., aiming to promote communication and cooperation between industry, academia, and research in the field of pharmacy, providing research directions for colleagues in the pharmaceutical field.

Dr. Zhang Xu from Haibu Pharmaceutical was invited to give a keynote report titled 'Research on Active Pharmaceutical Ingredients for Inhalation Formulations' at this forum, sharing and communicating with experts present on-site regarding the difficulties and issues related to active pharmaceutical ingredients for inhalation formulations.

Haibu Pharmaceutical focuses on the research and development of chemical drugs. The varieties under development involve multiple therapeutic areas including anti-tumor, mental health disorders, cardiovascular diseases, digestive diseases, respiratory diseases, anti-infection among others. The company is committed to becoming the most trusted drug development partner for its clients.

The successful holding of this forum has promoted communication between industry, academia, and research in the pharmaceutical sector, improved the level of drug formulation R&D and processes, elevating domestic drug quality and its quality management system to a new level.